Research graph
References from Lipid‐Lowering Effects of Inclisiran in Statin‐ or PCSK9i Monoclonal Antibody‐Intolerant Individuals. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1161/circulationaha.122.063460
10.1161/circulationaha.122.063460 · External reference
10.1056/nejmoa1912387
10.1056/nejmoa1912387 · External reference
10.1016/j.jacl.2023.09.005
10.1016/j.jacl.2023.09.005 · External reference
10.1016/j.jacl.2025.06.015
10.1016/j.jacl.2025.06.015 · External reference
10.1016/j.jacc.2025.04.049
10.1016/j.jacc.2025.04.049 · External reference
10.1016/j.jacc.2025.04.049
10.1016/j.jacc.2025.04.049 · ExternalCitation · doi-reference
10.1016/j.jacl.2023.09.005
10.1016/j.jacl.2023.09.005 · ExternalCitation · doi-reference
10.1016/j.jacl.2025.06.015
10.1016/j.jacl.2025.06.015 · ExternalCitation · doi-reference
10.1056/nejmoa1912387
10.1056/nejmoa1912387 · ExternalCitation · doi-reference
10.1161/circulationaha.122.063460
10.1161/circulationaha.122.063460 · ExternalCitation · doi-reference
